Iron Deficiency Anemia
📧 Sign up to get email alerts when something new happens for Iron Deficiency Anemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-08-04FDA Approved: MONOFERRIC — Supplemental Application (Pharmacosmos Therapeutics Inc.)
FDA approved a supplemental application for MONOFERRIC (ferric derisomaltose) from Pharmacosmos Therapeutics Inc.
-
CLINICAL_TRIALS trial_result · 2022-07-20Clinical Trial Update: Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS [Phase 3]
Phase 3 trial update evaluating ferric derisomaltose/iron isomaltoside for recovery in gynecologic oncology ERAS programs; results not yet r…
-
CLINICAL_TRIALS trial_result · 2022-06-22Clinical Trial Update: Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA [Phase 3]
Phase 3 multicenter randomized trial evaluating intravenous ferric carboxymaltose (FCM) in pediatric iron deficiency anemia has completed wi…
-
FDA approval · 2022-06-16FDA Approved: FERAHEME — Supplemental Application (AMAG Pharmaceuticals, Inc.)
FDA approved a supplemental application for Feraheme (ferumoxytol) from AMAG Pharmaceuticals.
-
FDA approval · 2022-06-01FDA Approved: ACCRUFER — Supplemental Application (Shield TX (UK) Ltd)
The FDA approved a supplemental application for ACCRUFER (ferric maltol) submitted by Shield TX (UK) Ltd.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy [Phase 4]
Phase 4 trial update on ferric carboxymaltose for treating iron-deficiency anemia in cancer patients with multiple myeloma on chemotherapy; …
-
CLINICAL_TRIALS trial_result · 2022-03-21Clinical Trial Update: Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044 [Phase 3]
Phase 3 trial evaluating intravenous ferric carboxymaltose for pediatric iron deficiency anemia with incomplete response to oral iron; resul…
-
CLINICAL_TRIALS trial_result · 2022-03-14Clinical Trial Update: The Efficacy of Intermittent Versus Daily Oral Iron Supplementation in Anaemic Pregnant Women. [Phase 4]
Phase 4 trial evaluating intermittent versus daily oral iron supplementation in anaemic pregnant women; status and results are not provided …
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: The Iron and Muscle Study [Phase 4]
Phase 4 trial update on the Iron and Muscle Study evaluating CKD patients with iron deficiency.
-
FDA approval · 2022-02-16FDA Approved: ACCRUFER — Supplemental Application (Shield TX (UK) Ltd)
FDA approved a supplemental application for ACCRUFER (ferric maltol) submitted by Shield TX (UK) Ltd. The action concerns an existing approv…
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia [Phase 3]
Phase 3 trial comparing thrice-weekly versus thrice-daily oral ferrous fumarate in adults with iron deficiency anemia completed.
-
FDA approval · 2022-02-04FDA Approved: INJECTAFER — Supplemental Application (American Regent, Inc.)
FDA approved a supplemental application for Injectafer (ferric carboxymaltose injection) submitted by American Regent, Inc.
-
FDA approval · 2021-11-19FDA Approved: INJECTAFER — Supplemental Application (American Regent, Inc.)
FDA approved a supplemental application for Injectafer (ferric carboxymaltose injection) from American Regent, Inc., resulting in an approve…
-
CLINICAL_TRIALS trial_result · 2021-11-08Clinical Trial Update: Treatment of (IDA) by (FPC) Delivered Via Infusion Pump in Patients Receiving Home Infusion Therapy [Phase 2]
Phase 2 clinical trial update evaluating FPC delivered via infusion pump for treating iron deficiency anemia in home infusion therapy.
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF) [Phase 3]
Phase 3 trial update for Ferinject in patients with iron deficiency and chronic heart failure.
-
FDA approval · 2021-09-14FDA Approved: INFED — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for INFED (iron dextran) from Allergan, Inc.
-
FDA approval · 2021-08-04FDA Approved: INJECTAFER — Supplemental Application (American Regent, Inc.)
FDA approves a supplemental application for Injectafer (ferric carboxymaltose injection) submitted by American Regent, Inc.
-
CLINICAL_TRIALS trial_result · 2021-07-12Clinical Trial Update: Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFER® (Vifor S.A., Switzerland), in Subjects With Mild and Moderate Iron Deficiency Anemia. [Phase 3]
A Phase 3 trial comparing Ferrum Lek (iron(III) hydroxide polymaltosate) to MALTOFER for mild to moderate iron deficiency anemia has complet…
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response and Transfusion in Patients With Iron Deficiency Anemia After Off-Pump Coronary Artery Bypass Grafting [Phase 4]
Phase 4 trial evaluating intravenous ferric carboxymaltose for hemoglobin response and transfusion needs in iron deficiency anemia patients …
-
FDA approval · 2021-04-28FDA Approved: INJECTAFER — Supplemental Application (American Regent, Inc.)
FDA approved a supplemental application for Injectafer (ferric carboxymaltose injection) from American Regent, Inc. The approval pertains to…
-
FDA approval · 2021-04-20FDA Approved: INFED — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for INFED (iron dextran) submitted by Allergan, Inc. This action authorizes changes to the product u…
-
CLINICAL_TRIALS trial_result · 2021-04-09Clinical Trial Update: Ferrous Acetyl-Aspartate Casein Formulation Evaluation Over Ferrous Sulfate in Iron Deficiency Anemia [Phase 4]
A Phase 4 trial comparing ferrous acetyl-aspartate-casein formulation to ferrous sulfate for iron deficiency anemia has been completed.
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial) [Phase 4]
A Phase 4 clinical trial update for KRX-0502 (ferric citrate) in patients with non-dialysis dependent chronic kidney disease and iron defici…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease [Phase 4]
A Phase 4 trial comparing the incidence of hypophosphatemia between iron isomaltoside and ferric carboxymaltose in subjects with iron defici…
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: Do Iron And Vitamin B12 Injections Given Together, Improve Hemoglobin In Patients On Hemodialysis? [Phase 4]
A Phase 4 trial assessing whether iron and vitamin B12 injections given together improve hemoglobin in patients on hemodialysis.